Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mauldin Economics is a financial publishing and investment research firm that provides macroeconomic analysis, geopolitical insights, and investment strategies to a global audience. Founded by renowned investor and author John Mauldin, the company offers a suite of subscription-based newsletters and research services designed to help investors navigate complex market cycles. Their flagship publication, 'Thoughts from the Frontline,' is one of the most widely read investment newsletters in the industry. While the firm is not a life sciences company, it frequently provides in-depth analysis of the biotechnology and healthcare sectors, particularly focusing on longevity and anti-aging technologies as key investment themes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mauldin Economics.